Top Emerging Trends Of Pessary Market Progress Forecast 2028 |Grand View Research, Inc.

Posted by Mrudula Anil Karmarkar on October 3rd, 2023

San Francisco, 03 October 2023: The ReportPessary Market Size, Share & Trends Analysis Report By Type (Gellhorn, Ring, Donut), By End-use (Hospitals, Ambulatory Surgical Centers, Clinics), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2021 - 2028

The global pessary market size is expected to reach USD 547.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2021 to 2028. An increase in the demand for pessaries has been witnessed in recent years as compared to the surgeries performed for pelvic organ prolapse. Easy and convenient application has largely favored the growing usage of pessaries among patients.

According to the U.S. Census Bureau, the number of women aged 65 years and above in America would double by 2030 to reach over 40 million. Vaginal pessaries have a high success rate and minimal complication rate for the treatment of both incontinence and prolapse. When successfully fitted, they are associated with high patient satisfaction.

Sedentary lifestyles and lifestyle-associated diseases are also expected to contribute to market growth. The increasing prevalence of diseases such as urinary inconsistency, pelvic organ prolapse and the rising number of geriatric population is fueling the demand for vaginal pessaries.

The market for vaginal pessary is competitive. The most notable participants in the market are CooperSurgical, Biotique America, and MedGyn. Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, CooperSurgical, based in the United States, invented the Milex Pessary Fitting Kit. The kit is designed for physicians and doctors who can use it to determine the exact size of the patient and prescribe the pessary accordingly. The introduction of these detailed analyses marks a significant shift in focus in the field of female healthcare around the world, which is propelling the market forward.

Increasing prevalence of pelvic organ prolapse, growing geriatric population that is prone to pelvic organ prolapse, easy product availability, changing lifestyles, and rapid evolution of noninvasive treatment options are expected to fuel market growth. Stress urine incontinence is higher in patients with poor nutritional status which results in weakening of pelvic muscles. Thus, the demand for advanced pelvic support devices is expected to show steep growth in upcoming years.

Request sample report of Pessary Market@https://www.grandviewresearch.com/industry-analysis/vaginal-pessary-market-report/request/rs1

Vaginal pessaries are one of the most preferred treatment options for organ prolapse and incontinence as they provide simple, affordable, and safe solutions. These factors contribute to a higher patient satisfaction rate as compared with the alternative treatment options. Thus, vaginal pessaries are now considered as first-line treatment of pelvic prolapse and/or stress urinary incontinence. Pelvic Organ Prolapse (POP) affects women of all ages. However, elderly women are more susceptible to POP complications. According to studies from the US Food and Drug Administration, the number of women with POP is predicted to rise by 46 percent by 2050, to 4.9 million.

Pessary Market Report Highlights

  • In terms of type, the ring pessary segment dominated the market in 2020, since the device is easy to insert and remove
  • The hospitals segment held the largest revenue share in 2020, as they are the primary point of care for treatment, furthermore, hospitals are known to offer superior care to their patients, and treatment at these centers are generally reimbursed, which drives adoption
  • The clinic segment is predicted to witness the fastest growth rate over the forecast timeframe due to the increasing number of patient visits and advanced infrastructure in clinics
  • North America dominated the market in 2020 due to the increasing R&D spending, rising demand for medication development, strong governmental efforts, and current projects
  • Asia Pacific is expected to register the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of pelvic organ prolapse

Pessaries were preferred as a temporary measure against delayed elective surgeries during the COVID-19 pandemic. However, the overall demand declined significantly during the first wave of COVID-19. This can be attributed to a decrease in overall footfall in clinics and hospitals during the pandemic. Lockdown and restriction on gathering directly affected the production during the first wave of COVID-19. However, the production units started reopening during the third quarter of 2020. The adoption of vaginal pessaries is impacted by the factors such as patient discomfort and fear of side effects. To address these issues, regulatory agencies such as the FDA and NICE have developed new guidelines for manufacturers.

Pessary Market Report Scope

Report Attribute

Details

Market size in 2021

USD 294.7 million

Revenue forecast in 2028

USD 547.2 million

Growth rate

CAGR of 9.2% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2021

Forecast period

2021 - 2028

List of Key Players of Pessary Market

  • CooperSurgical Inc.
  • Bliss GVS Pharma
  • MedGyn
  • Panpac Medical Corporation
  • Bioteque America
  • Personal Medical Corporation
  • Dr. Arabin GmbH & Co. KG
  • Integra Lifesciences
  • Wallach Surgical Devices

Like it? Share it!


Mrudula Anil Karmarkar

About the Author

Mrudula Anil Karmarkar
Joined: July 2nd, 2020
Articles Posted: 1,960

More by this author